{
	"columns": [
		{
			"label": "SimilarStudyID",
			"field": "SimilarStudyID"
		},
		{
			"label": "Title",
			"field": "Title"
		},
		{
			"label": "StudyLink",
			"field": "StudyLink"
		}
    ],
	
	"rows":[
   {
      "SimilarStudyID":"NCT00794950",
      "Title":"A Phase II Study of Intravesical Bacillus Calmette-Guerin Followed by Sunitinib for the Treatment of High Risk Non-muscle Invasive Lower Urinary Tract Urothelial Carcinoma",
      "StudyLink":"https://clinicaltrials.gov/ct2/show/results/NCT00794950"
   },
   {
      "SimilarStudyID":"NCT01023958",
      "Title":"An Open-label, Single-arm, Phase II Trial of Intravenous BI 6727 in Patients With Locally Advanced, Metastatic or Recurrent Urothelial Cancer of the Bladder, Renal Pelvis, or Ureters After Failure of Prior Chemotherapy",
      "StudyLink":"https://clinicaltrials.gov/ct2/show/results/NCT01023958"
   },
   {
      "SimilarStudyID":"NCT01373294",
      "Title":"Immune Modulation by Addition of Oral Lenalidomide to Intravesical BCG (Bacille Calmette-Guerrin) for Therapy of Non-muscle-invasive Transitional Cell Bladder Cancer",
      "StudyLink":"https://clinicaltrials.gov/ct2/show/results/NCT01373294"
   }
]
}